| » | The API synthesis process for an orphan drug that our client had developed lead to several unknown interfering impurities. |
| » | IDrug was contracted to identify these impurities to support the client in avoiding their formation. |
| » | IDrug conducted a structure determination of undesirable impurities using GC/MS, HPLC/MS/MS and NMR. |
| » | 2 weeks from first discussions with client to final delivery of structure determination |
| » | Results were the basis for the optimizing the current synthesis process. |